PT-141 (Bremelanotide): A Libido Peptide That Works Through the Brain, Not Blood Vessels

You know what's interesting? Most people think libido problems are about blood flow. About blood vessels. About the same thing Viagra treats. And then a drug appears that works completely differently. It goes straight to the brain.

PT-141, also known as Bremelanotide or under the brand name Vyleesi, received FDA approval in June 2019 [1]. It's the first and only drug of its type approved for treating decreased sexual desire. And it has nothing in common with Viagra in terms of mechanism.

If you or your partner have faced situations where pills simply don't work, this article is for you.

What is PT-141 (Bremelanotide) — and why it's not "just another pill"

The history of PT-141 begins with a surprise. When scientists at Palatin Technologies were testing the drug Melanotan II for artificial tanning, study participants began reporting an unexpected side effect — spontaneous erections [30]. This was an accidental discovery, but it changed the direction of research.

Scientists isolated the molecule responsible for this effect and called it PT-141. Years of clinical trials followed. In 2019, the FDA approved the drug under the name Vyleesi for treating hypoactive sexual desire disorder (HSDD) in women [2].

PT-141 is a synthetic peptide, an analog of alpha-melanocyte-stimulating hormone [12]. Its amino acid sequence is designed to activate specific receptors in the central nervous system. Not in blood vessels. Not in sexual organs. In the brain.

This is what makes it fundamentally different from everything that came before.

Mechanism of action — why PT-141 works through the head, not through blood vessels

Here's where it gets really interesting. When you take Viagra or Cialis, these drugs block the PDE-5 enzyme in blood vessels of sexual organs. The result — more blood, better erection. But desire, arousal, "wanting" — they don't affect that at all [25].

PT-141 works completely differently. It binds to melanocortin receptors in the central nervous system, primarily MC4R and MC1R [4]. MC4R receptors are found in many brain areas, including the hypothalamus — the center that controls basic instincts, including sexual desire [10].

Interestingly, the exact mechanism by which PT-141 improves sexual desire is still not fully understood by scientists. The official FDA instructions directly state: "The mechanism by which Vyleesi improves HSDD in women is unknown" [4]. But we know that MC4R activation in the brain modifies neural pathways related to sexual response [39].

And MC1R? This receptor is responsible for skin pigmentation. That's why darkening of moles can be among the side effects. But more on that later.

Who PT-141 works for — and who should pay attention

Officially, Vyleesi is approved for premenopausal women with HSDD [5]. But clinical practice is much broader.

Women with hypoactive sexual desire disorder

The RECONNECT clinical studies (Study 301 and 302) included 1,247 women [3]. Results showed statistically significant improvement in sexual desire scores compared to placebo. In Study 301, the FSFI-D (Female Sexual Function Index desire domain) score increased by 0.54 points in the bremelanotide group versus 0.24 in the placebo group (p < 0.0002) [3].

Approximately 25% of patients receiving Vyleesi noted an increase in sexual desire score of 1.2 points or more, compared to 17% in the placebo group [5].

Men who don't respond to Viagra or Cialis

Here's where it gets really interesting. Although PT-141 isn't FDA-approved for men, clinical studies are actively ongoing. Palatin Technologies launched a Phase II study for men with erectile dysfunction who don't respond to PDE-5 inhibitor therapy [26].

Early studies showed promising results. In a small clinical trial, up to 70% of men noted significant improvement in sexual function on the PGI-I (Patient Global Impression of Improvement) scale [30]. Research by Safarinejad and Hosseini demonstrated that bremelanotide helps men who didn't respond to sildenafil [22].

That's why many doctors prescribe PT-141 off-label for men.

Cases where the cause is psychogenic

When erection problems have psychological roots — stress, anxiety, depression, relationship problems — blood flow pills can be useless [25]. Because physically everything works, but the signal from the brain just isn't going. PT-141 works precisely at this level of the problem.

Post-SSRI sexual dysfunction

SSRI antidepressants are known for suppressing libido. Sometimes this effect persists even after stopping the medication. Since PT-141 works through a different mechanism — the melanocortin system, not the serotonin system — it may be an option for this patient group.

PT-141 is available in the DOZA catalog — 3,500 UAH per vial.

Application protocol — how much, when, and how often

Officially approved dosage for women: 1.75 mg subcutaneously [4]. The injection is given in the abdomen or thigh at least 45 minutes before planned sexual activity [31].

Why not more than 8 times per month?

This limitation is based on clinical trial data. In trials, most patients used Vyleesi 2-3 times per month, not more than once per week [5]. With more frequent use, the risk of side effects increases, particularly elevated blood pressure and hyperpigmentation [15].

How to select the dose

If you're just starting, it makes sense to start with a lower dose — 0.5-1 mg [23]. This allows you to assess individual tolerance. Nausea, the most common side effect, often decreases with the second dose [4]. So even if the first experience wasn't ideal, it makes sense to try again.

Technical aspects

Vyleesi comes as a ready-to-use autoinjector [2]. For those working with research peptides, typical vial sizes are 5 mg or 10 mg [23]. Reconstitution is done with bacteriostatic water.

The optimal window for administration is not yet fully characterized in studies [31], but 45-60 minutes before activity is the standard recommendation.

Side effects — what really happens in the body

Now for the less pleasant part. PT-141 isn't candy, and it has its "buts." Let's honestly break down what can happen.

Nausea — the most common reaction

Forty percent — that's a lot. Nausea can last 2 hours or more [11]. 13% of patients required antiemetic therapy, and 8% stopped taking it altogether due to this symptom [4].

But here's what's important: in most people, nausea decreases with the second dose [4]. If the first time was unpleasant, the second may be much easier.

Flushing — hot flashes

About 20% of patients experience redness and warmth in the face and chest [5]. This is related to vasodilation and usually resolves on its own.

Injection site reactions

13% report redness, swelling, or discomfort at the injection site [5]. Standard reaction for subcutaneous injections.

Headache

11% of patients noted headache [5]. Usually mild and short-term.

Blood pressure elevation — important for people with hypertension

This is more serious. PT-141 temporarily raises blood pressure: on average by 1.9 mmHg systolic and 1.7 mmHg diastolic [10]. Usually readings return to normal within 12 hours [4].

The FDA Multidisciplinary Review states: "These transient blood pressure elevations with use up to 8 doses per month are not expected to significantly increase cardiovascular disease risk in the target population, which generally has low cardiovascular risk" [15].

Hyperpigmentation — darkening of moles

Remember the MC1R receptor? It's responsible for melanin. About 1% of patients reported focal hyperpigmentation, including face, gums, and breasts [4]. Risk is higher in people with darker skin and with daily dosing.

PT-141 vs Viagra vs Cialis — comparative table

Here's the key question: how does PT-141 differ from what's already available? Let's compare directly.

Main difference — what they do

Vyleesi activates pathways in the brain involved in the body's normal sexual response [32]. It stimulates melanocortin receptors associated with regulating mood, thinking, and pigmentation. These receptors may contribute to the aphrodisiac effect [36].

PDE-5 inhibitors simply dilate blood vessels. If the problem is desire — they're powerless.

Alcohol compatibility — a nice bonus

Vyleesi has no restrictions on alcohol consumption [5]. This is a significant advantage, as many couples want to have a glass of wine at dinner. For comparison: the first female libido drug, Addyi (flibanserin), initially had strict warnings about alcohol [5].

When PT-141 might be the better choice

Studies have shown that bremelanotide helps men who didn't respond to PDE-5 monotherapy. Moreover, when intranasal bremelanotide was combined with a PDE-5 inhibitor, erectile response was statistically better than PDE-5 alone [27].

Who should NOT take PT-141 — contraindications

Honesty is more important than sales. PT-141 isn't suitable for everyone, and there are categories of people for whom it's contraindicated.

Uncontrolled hypertension or cardiovascular disease

This is a direct contraindication in the official FDA instructions [4]. Vyleesi is not recommended for patients with high cardiovascular risk [4]. Before starting, it's important to ensure blood pressure is controlled.

People with allergies to components

The drug contains bremelanotide acetate, glycerin, water, sodium hydroxide, and hydrochloric acid [35]. If there's an allergy to any component — PT-141 isn't an option.

Pregnancy and breastfeeding

Standard contraindication for most drugs in this class. Insufficient safety data.

Postmenopausal women

Officially, Vyleesi isn't indicated for postmenopausal women [31]. Clinical studies were conducted only on premenopausal women, and the FDA hasn't approved use for other populations.

Men (officially)

The paradox of the situation: the drug isn't FDA-approved for men [31], although the first observations of effects were in men, and men make up a significant portion of off-label users. Studies continue, but there's no official approval yet.

Not for "performance enhancement"

Important clarification: Vyleesi isn't intended for enhancing sexual performance in healthy people [31]. It's a medical drug for a specific condition, not a "pleasure pill."

Legal status of PT-141 in Ukraine and Europe — what's legal

The situation here is ambiguous. Different countries have different rules.

USA

PT-141 is FDA-approved under the brand Vyleesi [34]. Prescription required. Sold as nasal spray or autoinjector. Everything is legal and transparent.

Europe

The European Medicines Agency (EMA) is still reviewing the drug [37]. Approval status varies by country: somewhere it's classified as a prescription drug, somewhere it remains unapproved [34].

Ukraine

In Ukraine, bremelanotide (PT-141) is not registered as a medication for general use. It's not available as a prescription drug in regular pharmacies.

Australia and Canada

Usually available only as a research chemical or through compounding pharmacies [34].

Gray market — big risk

And here's an important warning. In June 2025, one of the largest online peptide suppliers was shut down by the FDA for selling incorrectly labeled and contaminated products [33]. The FDA found contamination in seized PT-141 samples [6].

The authoritative publication PeptidesExplorer clearly explains the situation: "Under federal law, selling a chemical for research purposes is permitted. Buying for research purposes is also permitted. What makes this a gray area: many buyers intend to inject these products into themselves, and many suppliers know this" [16].

What a practical protocol looks like — step by step

If you've decided to try PT-141, here's how it usually happens in practice.

Preparation

1. Specialist consultation is not optional. PT-141 affects the cardiovascular system, and it's important to ensure it's safe specifically for you.
2. Blood pressure check — baseline measurement before starting therapy.
3. Getting the product from a reliable source. DOZA offers PT-141 with full support and consultation.

Day of use

• 45-60 minutes before planned activity
• Subcutaneous injection in abdomen or thigh
• Starting dose: 0.5-1 mg to assess tolerance
• Optimal dose: 1.75 mg (FDA-approved)

After injection

• Possible nausea within the first 2 hours
• Possible flushing of face and chest
• Effect begins in 45-60 minutes
• Duration — several hours (half-life ~2.7 hours [23])

Frequency

• Not more than once per 24 hours
• Not more than 8 times per month
• Most users — 2-3 times per month [5]

Where to buy

DOZA supplies the products mentioned in this article with an official cold chain and 24/7 specialist support:

• Buy PT-141 in Ukraine — Bremelanotide for libido, acting via the CNS.

FAQ — most common questions about PT-141

How fast does PT-141 work and how long does the effect last?

PT-141 starts working 45-60 minutes after injection. The effect lasts several hours. The drug's half-life is about 2.7 hours, meaning concentration decreases by half every 2-3 hours.

Can PT-141 be combined with alcohol?

Yes. Unlike some other libido medications, PT-141 (Vyleesi) has no restrictions on alcohol consumption. This is one advantage compared to Addyi, the first approved female libido medication.

Can it be combined with Viagra or Cialis?

Studies show that combining bremelanotide with PDE-5 inhibitors may provide better results than PDE-5 alone. Palatin Technologies is currently conducting Phase II studies of this combination for men. However, you shouldn't combine medications on your own—specialist consultation is needed.

Why does PT-141 cause nausea and how to manage it?

Nausea occurs due to effects on the central nervous system. It's the most common side effect experienced by about 40% of users. Helpful strategies: start with a lower dose, take ginger or anti-nausea medication 30 minutes before injection. Usually nausea decreases with the second and subsequent doses.

PT-141 or Bremelanotide — what's the difference?

They're the same molecule. PT-141 is the research name, Bremelanotide is the international nonproprietary name (INN), Vyleesi is the brand name of the FDA-approved drug from Palatin Technologies and AMAG Pharmaceuticals.

Is PT-141 legal in Ukraine?

PT-141 is not registered as a medication in Ukraine. It's available through compounding pharmacies and as a research peptide. DOZA offers PT-141 with specialist consultation and product quality control.

For whom will PT-141 be useless?

PT-141 won't help if the problem is purely mechanical or vascular without a psychogenic component. It's also not indicated for healthy people who simply want to "improve performance." This is a medical drug for specific conditions, not an aphrodisiac for entertainment.

Summary — is PT-141 worth considering

PT-141 (Bremelanotide) is truly an innovative approach to libido problems. It doesn't compete with Viagra. It fills a different niche — for people whose problem isn't blood flow, but desire.

The 2019 FDA approval confirms: the drug works and has an acceptable safety profile [1]. Active research for men shows promise [26]. The mechanism through MC4R in the brain is unique among available options [4].

But it's not a magic pill. Nausea in 40% of cases is reality [4]. Cardiovascular contraindications are too [4]. And it's definitely not an option for self-medication without consultation.

If you or your partner face decreased libido that doesn't respond to conventional approaches — PT-141 is worth discussing with a specialist. Not to sell you a product. But to understand if this is truly your case.

PT-141 in the DOZA catalog — 3,500 UAH. Consultation is free.

*Also read: *Peptides for Men 2026 — From Libido to Prostate